Easterly Investment Partners LLC Standard Biotools Inc. Transaction History

Easterly Investment Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	BUY	$4.35 - $6.35 $59,473 - $86,817	13,672 New	13,672 $84,000
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $70,773 - $112,328	-12,986 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.34 - $11.43 $421,513 - $1.11 Million	-97,123 Reduced 88.21%	12,986 $96,000
Q2 2020 Aug 14, 2020	SELL	$1.85 - $5.29 $6.61 Million - $18.9 Million	-3,573,631 Reduced 97.01%	110,109 $442,000
Q1 2020 May 13, 2020	SELL	$1.24 - $4.35 $867,884 - $3.04 Million	-699,907 Reduced 15.97%	3,683,740 $9.36 Million
Q4 2019 Feb 11, 2020	SELL	$2.3 - $5.12 $1.46 Million - $3.25 Million	-634,557 Reduced 12.65%	4,383,647 $15.3 Million
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $13.3 Million - $35 Million	-2,876,999 Reduced 36.44%	5,018,204 $23.2 Million
Q2 2019 Aug 13, 2019	SELL	$11.49 - $14.17 $16.5 Million - $20.3 Million	-1,431,907 Reduced 15.35%	7,895,203 $97.3 Million
Q1 2019 May 13, 2019	BUY	$8.47 - $14.36 $79 Million - $134 Million	9,327,110 New	9,327,110 $124 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Easterly Investment Partners LLC with notifications on news.